Bayer

Showing 15 posts of 262 posts found.

Bayer invests 35m euros in biologics production

December 14, 2010
Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production

Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …

Age-related macular degeneration (Wet AMD)

Bayer’s challenger to Lucentis shows promise

November 22, 2010
Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …

Bayer set for 4,500 job cuts

November 19, 2010
Research and Development, Sales and Marketing Bayer, Cost cutting, emerging markets

Bayer has announced large scale job losses aimed at saving 800 million euro savings in the coming years.The cuts are …

Bayer's Levitra

Bayer faces ABPI audit after “shocking” Levitra error

November 5, 2010
Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Bayer, PMCPA

Bayer has been accused of a “shocking error of judgement” after promotional material for its erectile dysfunction brand Levitra (vardenafil) …

New form of Levitra wins EU approval

September 7, 2010
Sales and Marketing Bayer, Levitra, erectile dysfunction

Bayer is to launch a new formulation of its erectile dysfunction drug Levitra. The European Commission granted Levitra (verdenafil HCI) …

Bayer signs Chinese research deal

July 20, 2010
Research and Development Bayer, China, gynaecology

Bayer is partnering with the People’s Liberation Army General Hospital in Beijing on research into women’s healthcare. The People’s Liberation …

GW laboratory

Bayer launches world’s first cannabis-derived prescription drug

June 21, 2010
Sales and Marketing Bayer, GW Pharmaceuticals, Sativex

Bayer Healthcare has launched the world’s first cannabis-derived prescription drug in the UK. Sativex treats the spasticity symptoms of multiple …

Nexavar fails in lung cancer trial

June 15, 2010
Research and Development Bayer, NSCLC, Nexavar, Onyx

Bayer and Onyx Pharmaceutical’s oncology drug Nexavar has failed to meet its primary endpoint in a phase III study for …

Bayer opens US ‘science hub’

May 18, 2010
Research and Development Bayer, US, acdemia, clinical research

Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …

Bayer colon cancer drug moves into phase III

May 11, 2010
Research and Development Bayer, colorectal cancer, regorafenib

Bayer Schering Pharma will shortly begin phase III tests of its investigational compound regorafenib for patients with metastatic colorectal cancer.  …

BayerJogReinhardt

Bayer lures Novartis’ Reinhardt for top healthcare post

April 22, 2010
Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing

German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …

Bayer pharma sales overcome European decline

February 26, 2010
Sales and Marketing 2009 financials, Bayer, Xarelto

Bayer’s group sales dropped 5% to 31 billion euros in a “difficult year” for the company that saw a drop …

Blog footer

Digital Pharma: Glucose monitoring for the Nintendo generation

January 20, 2010
Medical Communications Bayer, diabetes, digi, digi game, digital pharma

The Nintendo DS that arrived in our house on Christmas has already become my eldest son’s most favourite present of …

Bayer Schering Pharma's Len Starnes

Digital Pharma: A Year in Digital (4/5)

December 15, 2009
Medical Communications 2009, Bayer, digi, digital pharma, year in review

Favourite use of digital (pharma)Physicians’ social networks. This is pharma’s new engagement channel offering the industry an opportunity to normalise …

Bayer takes Alzheimer’s diagnostic into pivotal trials

December 2, 2009
Research and Development Alz, Bayer, diagnostic

An imaging agent that can detect amyloid plaques in the brains of Alzheimer’s patients and so may provide an accurate …

The Gateway to Local Adoption Series

Latest content